We could previously show [24] that in TP53-mutated ELF-153 AML cells that have lost one allele of 17p (i.e., the region bearing both the TP53 and HIC1 loci), HIC1 expression from the remaining allele was particularly strong upon DAC treatment. This evidence concerns the gene TP53 and acute myeloid leukemia.